|Articles|September 2, 2001
- Pharmaceutical Technology-09-02-2001
- Volume 25
- Issue 9
Replacing the Animal Component in SerumEvaluating Raw Materials for Inclusion in Optimized Hybridoma Media
With the scarcity of CGMP facilities spurring a production crisis, manufacturers need to optimize their processes and formulations for individual hybridoma cell lines and production systems.
Advertisement
Articles in this issue
about 24 years ago
Six Sigma Can Give Contractors a Quality Advantageabout 24 years ago
Industry Changes OTC Labels as Deadline Approachesabout 24 years ago
A Report of the PQRI Workshop on Blend Uniformityabout 24 years ago
Are You Ready for Global Manufacturing?about 24 years ago
Pharmaceutical Coverage and Costsabout 24 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Trends in Bioanalysis
2
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
